Dermatofibrosarcoma Protuberans — Trials

Dermatofibrosarcoma Protuberans — Trials · CancerIndex

Clinical trials

Registered studies

16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06239272	NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)	recruiting	Phase 1 / Phase 2	139	St. Jude Children's Research HospitalOTHER	1	Aug 3, 2026	clinicaltrials
NCT07646080	Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans	not yet recruiting	Phase 2	20	Yanjie Zhang, MDOTHER	0	Jun 16, 2026	clinicaltrials
NCT01962103	Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors	completed	Phase 1 / Phase 2	107	CelgeneINDUSTRY	7	Dec 27, 2019	clinicaltrials
NCT01154452

Data updated 22 days agoSource updated Aug 3, 2026source: clinicaltrials